02415 梅斯健康
MEDSCI
MEDSCI
| Listing Date | 2023/04/27 |
| Listing Price | 9.100 |
Quote
Subscription Result
- Subscription Rate9.85x
- Guarantee One Lot Size8 lot
- One Lot Success Rate20%
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
MedSci Healthcare Holdings operates online professional physician platforms in China. As of December 31, 2022, its platform had approximately 2.9 million registered physician users and average MAU reached approximately 2.7 million in 2022.
--
Its MedSci platform also features a high percentage of experienced physicians with the title of associate-chief physician and above. As of December 31, 2021, the total number of registered physician users on MedSci platform who had the title of associate-chief physician and above represented 67.1% of the total number of physicians in China who had obtained the title of associate-chief physician and above, based on the latest published information from the NHC.
--
While key functions of the MedSci platform are self-developed, third parties, primarily pharmaceutical and medical device companies, also provide ancillary support, such as academic medical contents they created or copyrighted. As of December 31, 2022, its platform featured over 15,800 videos that share medical knowledge, covered over 644,000 research findings,
--
The Group realizes monetization by offering different solutions to address various needs of platform participants, primarily including pharmaceutical and medical device companies and physicians. They are mainly divided into three solution categories, namely, precision omni-channel marketing solutions, physician platform solutions and RWS solutions.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 250 |
GLOBAL OFFERING
| No. of Offer Shares | 66.79M shares |
| No. of International Offer Shares | 60.11M shares |
| No. of HK Offer Shares | 6.68M shares |
| Offer Price | $9.10 - $10.16 |
| Stock Code | 2415 |
| Sponsor(s) | China International Capital Corporation Hong Kong Securities Limited, Macquarie Capital Limited |
| Underwriter(s) | China International Capital Corporation Hong Kong Securities Limited, Macquarie Capital Limited, CCB International Capital Limited, Haitong International Securities Company Limited, Essence International Securities (Hong Kong) Limited, Dragonstone Capital Management Limited, China Everbright Securities (HK) Limited, First Shanghai Securities Limited, First Capital Securities Limited, Zhongtai International Securities Limited, Futu Securities International (Hong Kong) Limited, uSmart Securities Limited, Silverbricks Securities Company Limited, Livermore Holdings Limited |
TIME TABLE
| Application Period | Apr 17 (Mon) - noon, Apr 20 (Thu) |
| Price Determination Date | Apr 20 (Thu) |
| Result Announcement Date | On or before Apr 26 (Wed) |
| Result Announcement Date | On or before Apr 26 (Wed) |
| Result Announcement Date | On or before Apr 26 (Wed) |
| Dealings in Shares commence on | Apr 27, 2023. (Thu) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 15X - 50X | 50X - 100X | Over 100X |
| % of total shares reallocated to HK Offer | 30% | 40% | 50% |
Sales Statistics (HKD)
| Offer Price | $9.10 - $10.16 |
| Capitalization | 5.53B - 6.17B |
| NAV / share ($) | $2.03 - $2.14 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 9.63, the net proceeds raised would be HKD 566.10M, of which |
| 45% : For business expansion, including developing and updating content and service offerings of physician platform solutions |
| 35% : Further technology development to enhance our technology and data capabilities |
| 15% : Potential investments and acquisitions |
| 5% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).